Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on May 04, 2023 12:20pm
116 Views
Post# 35430294

What could RALI-Dx do for Doctors and Hospitals? (Triage)

What could RALI-Dx do for Doctors and Hospitals? (Triage) Conclusions: The rapid diagnostic biomarker panel accurately identified the need for inpatient care in patients presenting with respiratory symptoms, including COVID-19. The RALI-Dx test is broadly and easily applicable across many jurisdictions, and represents an important diagnostic adjunct to advance ED decision-making protocols.

We eagerly anticipate more quantitiative results to be shared as further data is presented.  While we have heard positive indications regarding RALI-Dx tests, we must think about the tangible results.  Being able to send patients home that otherwise would have taken a bed and associated care/costs, is significant.  This is especially true when you can reduce patient admission by a double digit percentage.  While even ten percent would be a good number, I believe the number will be superior.  For those that have followed details around SQI's sister test (TOR-Dx) it has been viewed as highly informative and is aiding in decision making in regards to organ transplant....(a high stakes event/decision).   

The other important consideration is the patient that the Doctor sends home based on how the patient appears to be doing.  There are a portion of patients that get released that soon return, and they are now in a lot worse condition with more serious consequences as a result.  Even a low single digit percent catch here is of great significance too, as the patient isn't wrongly sent home.

Driving better, more informed decision making is in everyones best interest.  At a time when resources are limited it is ever more important.  This ability to provide better and more efficient care is a worldwide opportunity.  Being able to get results quickly at point of care/need is massive, and makes adoption an obvious choice.

I understand why some suggest SQI has "Change the World Products".             
<< Previous
Bullboard Posts
Next >>